HIF1A and Alzheimer disease: This is in accordance with previous findings describing an upregulation of oncogenic signaling pathways in AD neurons (iNs and PM brain tissue), including HIF1α signaling that is aberrantly activated despite a normoxic environment (Marinaro et al., 2020; Mertens et al., 2021).